Colgate-Palmolive (NYSE:CL) Price Target Lowered to $104.00 at UBS Group

Colgate-Palmolive (NYSE:CL) had its target price lowered by UBS Group from $112.00 to $104.00 in a research report released on Thursday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts also recently weighed in on CL. TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price objective for the company from $105.00 to $101.00 in a report on Monday, October 28th. Finally, JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $102.11.

Colgate-Palmolive Stock Up 0.9 %

Shares of Colgate-Palmolive stock opened at $88.61 on Thursday. The stock has a 50-day moving average price of $92.32 and a 200 day moving average price of $97.85. The company has a market cap of $72.40 billion, a P/E ratio of 25.39, a P/E/G ratio of 3.01 and a beta of 0.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1 year low of $79.69 and a 1 year high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.26%. Colgate-Palmolive’s payout ratio is currently 57.31%.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.37% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Colgate-Palmolive

A number of institutional investors have recently made changes to their positions in the stock. Gordian Advisors LLC acquired a new position in Colgate-Palmolive in the third quarter valued at about $602,000. Carrera Capital Advisors grew its stake in Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after acquiring an additional 7,353 shares during the period. Vontobel Holding Ltd. grew its stake in Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after acquiring an additional 550,750 shares during the period. Fiduciary Alliance LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at about $4,066,000. Finally, Handelsbanken Fonder AB grew its stake in Colgate-Palmolive by 10.9% in the third quarter. Handelsbanken Fonder AB now owns 332,972 shares of the company’s stock valued at $34,566,000 after acquiring an additional 32,624 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.